These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9105089)
21. Comparative effects of salmeterol, albuterol, and ipratropium on normal and impaired mucociliary function in sheep. Sabater JR; Lee TA; Abraham WM Chest; 2005 Nov; 128(5):3743-9. PubMed ID: 16304342 [TBL] [Abstract][Full Text] [Related]
22. Effects of salmeterol on secretion of phosphatidylcholine by alveolar type II cells. Kumar VH; Christian C; Kresch MJ Life Sci; 2000 Mar; 66(17):1639-46. PubMed ID: 11261593 [TBL] [Abstract][Full Text] [Related]
23. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms. Chong LK; Cooper E; Vardey CJ; Peachell PT Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032 [TBL] [Abstract][Full Text] [Related]
24. The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions. Petersen LJ; Skov PS Inflamm Res; 1999 Oct; 48(10):527-32. PubMed ID: 10563469 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of the late phase reduction in lung functions and correlations with microvascular leakage and lung edema in allergen-challenged Brown Norway rats. Mauser PJ; House A; Jones H; Correll C; Boyce C; Chapman RW Pulm Pharmacol Ther; 2013 Dec; 26(6):677-84. PubMed ID: 23523662 [TBL] [Abstract][Full Text] [Related]
26. Mediator involvement in antigen-induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats. Hele DJ; Birrell MA; Webber SE; Foster ML; Belvisi MG Br J Pharmacol; 2001 Jan; 132(2):481-8. PubMed ID: 11159698 [TBL] [Abstract][Full Text] [Related]
27. Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo. Teixeira MM; Hellewell PG Eur J Pharmacol; 1997 Apr; 323(2-3):255-60. PubMed ID: 9128847 [TBL] [Abstract][Full Text] [Related]
28. Effects of phosphodiesterase inhibitors and salbutamol on microvascular leakage in guinea-pig trachea. Planquois JM; Mottin G; Artola M; Lagente V; Payne A; Dahl S Eur J Pharmacol; 1998 Feb; 344(1):59-66. PubMed ID: 9570449 [TBL] [Abstract][Full Text] [Related]
29. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol. Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724 [TBL] [Abstract][Full Text] [Related]
30. Effects of salmeterol on muscarinic inhibition of adenylyl cyclase in bovine trachealis cells. Ethier MF; Dextradeur T; Schaefer OP; Madison JM Life Sci; 2000 Oct; 67(22):2753-8. PubMed ID: 11105991 [TBL] [Abstract][Full Text] [Related]
31. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils. Koopmans JG; Lutter R; Jansen HM; van der Zee JS J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368 [TBL] [Abstract][Full Text] [Related]
32. Salmeterol does not alter increased bronchial responsiveness caused by organic dust exposure. Ek A; Palmberg L; Sundblad BM; Larsson K Chest; 2005 Oct; 128(4):3038-47. PubMed ID: 16236984 [TBL] [Abstract][Full Text] [Related]
33. Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopic patients. Grönneberg R; van Hage-Hamsten M; Halldén G; Hed J; Raud J Allergy; 1996 Sep; 51(9):640-6. PubMed ID: 8899116 [TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of salmeterol on the respiratory burst of adherent human neutrophils. Ottonello L; Morone P; Dapino P; Dallegri F Clin Exp Immunol; 1996 Oct; 106(1):97-102. PubMed ID: 8870705 [TBL] [Abstract][Full Text] [Related]
35. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. Ryall JG; Sillence MN; Lynch GS Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501 [TBL] [Abstract][Full Text] [Related]
36. The role of endogenous corticosterone in the late-phase response to allergen challenge in the brown Norway rat. Turner DJ; Myron P; Powell WS; Martin JG Am J Respir Crit Care Med; 1996 Feb; 153(2):545-50. PubMed ID: 8564095 [TBL] [Abstract][Full Text] [Related]
37. Effect of mometasone furoate (MF)/formoterol fumarate (F) combination (MF/F) on late-phase responses in allergen-challenged Brown Norway rats. Chapman RW; Curran AK; House A; Richard J; Salisbury B; Hunter JC; Anthes JC; Phillips JE Pulm Pharmacol Ther; 2011 Feb; 24(1):67-73. PubMed ID: 20937404 [TBL] [Abstract][Full Text] [Related]
38. The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists. Jack D Br J Clin Pharmacol; 1991 May; 31(5):501-14. PubMed ID: 1679656 [No Abstract] [Full Text] [Related]
39. Anti-edema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves. Sulakvelidze I; McDonald DM Am J Respir Crit Care Med; 1994 Jan; 149(1):232-8. PubMed ID: 7509246 [TBL] [Abstract][Full Text] [Related]
40. Salmeterol, a beta2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice. Maris NA; van der Sluijs KF; Florquin S; de Vos AF; Pater JM; Jansen HM; van der Poll T Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1122-8. PubMed ID: 14729506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]